Vertex Presents New Data on the Benefits of ALYFTREK
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is one of the 13 Biotech Stocks with Huge Upside Potential.
Posts Tagged ‘NASDAQ:VRTX’
13 Biotech Stocks with Huge Upside Potential
The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce reductions.
15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies
Even after his passing in 2024, billionaire investor and mathematician Jim Simons remains known as the "Quant King" of hedge funds due to the extraordinary success of Renaissance...
Vertex Pharmaceuticals Incorporated (VRTX) Surged On a Recovery in Investor Sentiment
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2025 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2025 Earnings Call Transcript May 5, 2025Vertex Pharmaceuticals Incorporated misses on earnings expectations.
21 Stocks on Jim Cramer’s Radar
“When you get a strong employment report like we did this morning, it does a lot of things that you need to know about.
Vertex Pharmaceuticals (VRTX) Surged on Increased Demand for its Cystic Fibrosis (CF) Franchise
GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
10 Best Long Term Growth Stocks to Buy According to Billionaires
As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, immigration, and global geopolitics, resulting in elevated...
Jim Cramer Nailed These 11 Stock Picks
On Thursday, April 3rd, the host of Mad Money opened the most recent show by addressing the growing concerns surrounding the current tariff policies.
8 Best Gene-Editing Stocks to Buy
Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to treat or prevent diseases.
Jim Cramer Looked At These 23 Stocks Recently
Jim Cramer, the host of Mad Money, offered an optimistic perspective on the market on Thursday as he challenged the prevailing pessimism among some on Wall Street.
Jim Cramer Discusses These 10 Stocks & Says US Faces Unfairly High Tariffs Abroad
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer reiterated that the Trump administration has to clarify its narrative about tariffs to convince the average American...
13 High Growth Large Cap Stocks To Invest In
After two years of 25%+ gains, some investors worry that stocks are overvalued.
15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
10 Best Diabetes Stocks To Buy According to Billionaires
The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income countries.
Should You Consider Adding Vertex Pharmaceuticals Incorporated (VRTX) to Your Portfolio?
Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 investor letter.
11 Best Pharma Stocks to Buy According to Hedge Funds
The US pharmaceutical sector is experiencing a distinct trend never seen before with large American pharma companies continually looking for medicines in China.
Renaissance Technologies Portfolio: Top 10 Stock Picks
The American quant hedge fund Renaissance Technologies is known for using statistical and mathematical tools to drive its investment programs.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2024 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2024 Earnings Call Transcript February 10, 2025Vertex Pharmaceuticals Incorporated misses on earnings expectations.
Jim Cramer Shed Light on These 9 Stocks
Jim Cramer, the host of Mad Money, has been considering the uncertainty surrounding 2025 and the ongoing macroeconomic challenges that are sparking important questions.
Vertex Pharmaceuticals Incorporated (VRTX) Slid due to Setbacks In Clinical Trials
ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” fourth quarter 2024 investor letter.
Jim Cramer’s Bold Predictions About These 10 Healthcare Stocks
Healthcare has been one of Jim Cramer's favorite topics lately.
Jim Cramer Discusses 17 Stocks And Blasts Zero Day Options
In his second appearance on Squawk on the Street after the Fed's interest rate cut, Jim Cramer had a lot to say about the Fed's decision and the Personal Consumption Expenditure...
10 Stocks That Will Make You Rich In 2025
Jurrien Timmer, Director of Global Macro at Fidelity Management & Research Company, recently shared his outlook for the stock market in 2025.
Jim Cramer Talked About These 17 Stocks After The Fed’s Rate Cut
The Federal Reserve created quite a bit of turmoil in the stock market on Wednesday when despite cutting interest rates, it signaled to investors that the journey to low rates...
Here’s Why Vertex Pharmaceuticals Incorporated (VRTX) Slid in Q3
Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity” third quarter 2024, investor letter.
6 Stocks Jim Cramer Talked About This Week
Jim Cramer, host of Mad Money, recently reflected on how investors often overlook obvious opportunities, particularly with cult stocks, which in hindsight appear to be clear success...
Goldman Sachs’ Top Growth Investors: 34 Stocks With The Highest Investment For Growth
With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future of artificial intelligence, the Federal Reserve's interest rate cut cycle...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q3 2024 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q3 2024 Earnings Call Transcript November 4, 2024Vertex Pharmaceuticals Incorporated beats earnings expectations.
Renaissance Technologies Portfolio: 10 Best Stocks To Buy
Renaissance Technologies is an American hedge fund that specializes in systematic trading and employs statistical and mathematical tools to drive its investment programs.
Reasons that Lifted Vertex Pharmaceuticals Incorporated (VRTX) in Q2
PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Jim Cramer’s 10 Go-To Stocks for Success
In a recent episode of Mad Money, Jim Cramer offers a perspective on Nvidia and its recent market behavior on Wednesday's episode of Mad Money, presenting a straightforward analysis...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q2 2024 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q2 2024 Earnings Call Transcript August 1, 2024Vertex Pharmaceuticals Incorporated misses on earnings expectations.
10 Best Healthcare Stocks to Buy According to Hedge Funds
In this article, we are going to discuss the 10 best healthcare stocks to buy according to hedge funds.
Vertex Pharmaceuticals (NASDAQ:VRTX): The Best Healthcare Stock to Buy in 2024?
We recently published a list Analyst Recommends 10 Best Stocks to Diversify Your Portfolio Away from Mega-Cap Tech and AI Stocks. Since Vertex Pharmaceuticals Incorporated (NASDAQ...
11 Best Feminist Stocks To Invest In
With the passage of time, the role of women in the modern day workplace has slowly started to grow.
Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) the Leading Gene Therapy Stock to Buy Now?
We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is the leading...
9 Best Gene Therapy Stocks to Buy Now
In this article, we will be discussing the best gene therapy stocks to buy now. Before we move on to our list, let's take a look at the market outlook for gene therapies and ...
Wall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets
In this article, we will discuss the 10 stocks whose price targets were recently raised by analysts.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.76, expectations were $4.07.
23 Most Profitable Stocks of the Last 12 Months
In this article, we discuss the 23 most profitable stocks of the last 12 months.
5 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 5 biggest biotechnology companies in the world.
5 Biotech Stocks with Huge Potential
In this article, we will take a look at the 5 biotech stocks with huge potential.
Reasons to Invest in Vertex Pharmaceuticals Incorporated (VRTX)
Aristotle Atlantic Partners, LLC, an investment management company, released its “Core Equity Strategy” fourth quarter 2023 investor letter.
20 Fastest Growing Biotech Companies in the US
In this article, we will be taking a look at the 20 fastest growing biotech companies in the US.
14 Best Medical Stocks To Invest In According to Hedge Funds
In this piece, we will take a look at the 14 best medical stocks to invest in according to hedge funds.
Top 5 CRISPR Stocks To Invest In
In this article, we discuss the top 5 CRISPR stocks to invest in.
30 Most Valuable Drug Companies in 2024
In this article, we will take a look at the 30 most valuable drug companies in 2024.
What Gives Vertex Pharmaceuticals Incorporated (VRTX) a Significant Competitive Advantage?
Harding Loevner, an asset management company, released its “Global Equity Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
